Moving catheter ablation forward from paroxysmal to persistent atrial fibrillation: progress, limitations, and surprises of the SARA trial
Eur Heart J
.
2014 Feb;35(8):482-4.
doi: 10.1093/eurheartj/eht504.
Epub 2013 Dec 25.
Authors
Gerhard Hindricks
1
,
Douglas L Packer
Affiliation
1
Department of Electrophysiology, Universitiy of Leipzig/Heart Centre, Strümpellstr. 39, D-04289 Leipzig/Germany.
PMID:
24371081
PMCID:
PMC3930874
DOI:
10.1093/eurheartj/eht504
No abstract available
Publication types
Editorial
Comment
MeSH terms
Anti-Arrhythmia Agents / therapeutic use*
Atrial Fibrillation / therapy*
Catheter Ablation / methods*
Female
Humans
Male
Substances
Anti-Arrhythmia Agents